Meta-analysis of ciltacabtagene autoleucel versus physician’s choice therapy for the treatment of patients with relapsed or refractory multiple myeloma
Current Medical Research and Opinion | July 11, 2022 | Volume: 38 | Issue: 10 | Pages: 1759-1767
10.1080/03007995.2022.2100651
| PMID 35815818